Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety

See also
Status	Clinical Trial	Phase
Completed	`NCT02256566` - Cognitive Training for Mood and Anxiety Disorders	N/A
Completed	`NCT01570400` - Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT	N/A
Recruiting	`NCT01388231` - Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice	Phase 2/Phase 3
Completed	`NCT00684541` - Interpretation Modification Program for Social Phobia	N/A
Completed	`NCT00380731` - Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia	N/A
Completed	`NCT00434759` - Social Phobia Intervention Study of Mannheim	N/A
Completed	`NCT03647605` - Pilot Study: VR Mind and VR Mind+ Intervention	N/A
Not yet recruiting	`NCT03241277` - Nonsurgical Periodontal Treatment in Patients With Social Phobia	N/A
Completed	`NCT02648737` - Cognitive Behavioural Therapy for Anxiety Disorders in PD	N/A
Completed	`NCT02294409` - Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis	N/A
Terminated	`NCT01979263` - Attention Bias Modification Treatment for Anxious Youth	N/A
Completed	`NCT01463137` - Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder	N/A
Completed	`NCT00774150` - Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study	N/A
Completed	`NCT00264654` - Long-term Study Of Paroxetine in Women and Men	Phase 3
Completed	`NCT00326430` - Residential Cognitive and Interpersonal Therapy for Social Phobia	Phase 2/Phase 3
Completed	`NCT00000389` - Treatment for Anxiety in Children	Phase 3
Completed	`NCT00397722` - Treatment Of Patients With Social Anxiety Disorder	Phase 2
Completed	`NCT02678624` - Project Collabri for Treatment of Anxiety	N/A
Completed	`NCT00564967` - A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy	Phase 3
Completed	`NCT00403962` - A Combination Therapy In Patients With Social Anxiety Disorder	Phase 2

NCT number	NCT01376271
Study type	Observational
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	N/A
Start date	January 2010
Completion date	September 2013

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms